During the past decade, Saskatchewan Cancer Agency conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 3 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 2 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Saskatchewan Cancer Agency" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 13 trials, followed by "SWOG Cancer Research Network" with 2 trials sponsored, "AHS Cancer Control Alberta" with 1 trials sponsored, "Gilead Sciences" with 1 trials sponsored and "McMaster University" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Saskatchewan Cancer Agency" #1 collaborator was "National Cancer Institute (NCI)" with 16 trials as a collaborator, "Eastern Cooperative Oncology Group" with 4 trials as a collaborator, "North Central Cancer Treatment Group" with 4 trials as a collaborator, "Cancer and Leukemia Group B" with 2 trials as a collaborator and "Radiation Therapy Oncology Group" with 2 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Saskatchewan Cancer Agency" are "Colorectal Cancer" (3 trials), "Lymphoma" (3 trials), "Breast Cancer" (2 trials), "Metastatic Cancer" (2 trials) and "Acute Leukemia" (1 trials). Many other conditions were trialed in "Saskatchewan Cancer Agency" in a lesser frequency.

Most popular intervention types in "Saskatchewan Cancer Agency" are "Drug" (19 trials), "Other" (3 trials), "Biological" (2 trials), "Radiation" (2 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "fluorouracil" (3 trials), "placebo" (3 trials), "cisplatin" (2 trials), "gemcitabine hydrochloride" (2 trials) and "irinotecan hydrochloride" (2 trials). Other intervention names were less common.

The vast majority of trials in "Saskatchewan Cancer Agency" are 20 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Saskatchewan Cancer Agency". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 18 completed trials in Saskatchewan Cancer Agency, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Saskatchewan Cancer Agency, 0 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".

Saskatchewan Cancer Agency has several departments that took part in Clinical trials: "Allan Blair Cancer Centre" - 326 trials, "Saskatoon Cancer Centre" - 322 trials